EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:65349 - mirabegron
| Formula | C21H24N4O2S |
| Net Charge | 0 |
| Average Mass | 396.516 |
| Monoisotopic Mass | 396.16200 |
| SMILES | Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1 |
| InChI | InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1 |
| InChIKey | PBAPPPCECJKMCM-IBGZPJMESA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. beta-adrenergic agonist An agent that selectively binds to and activates β-adrenergic receptors. |
| Applications: | renoprotective agent Any compound that is able to prevent damage to the kidneys. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. renal agent A drug used for its effect on the kidneys' regulation of body fluid composition and volume. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. beta-adrenergic agonist An agent that selectively binds to and activates β-adrenergic receptors. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| mirabegron (CHEBI:65349) has role analgesic (CHEBI:35480) |
| mirabegron (CHEBI:65349) has role cardiovascular drug (CHEBI:35554) |
| mirabegron (CHEBI:65349) has role renal agent (CHEBI:35846) |
| mirabegron (CHEBI:65349) has role renoprotective agent (CHEBI:231911) |
| mirabegron (CHEBI:65349) has role β-adrenergic agonist (CHEBI:35522) |
| mirabegron (CHEBI:65349) is a 1,3-thiazoles (CHEBI:38418) |
| mirabegron (CHEBI:65349) is a aromatic amide (CHEBI:62733) |
| mirabegron (CHEBI:65349) is a ethanolamines (CHEBI:23981) |
| mirabegron (CHEBI:65349) is a monocarboxylic acid amide (CHEBI:29347) |
| IUPAC Name |
|---|
| 2-(2-amino-1,3-thiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy-2-phenylethyl]amino}ethyl)phenyl]acetamide |
| INN | Source |
|---|---|
| mirabegron | ChemIDplus |
| Synonyms | Source |
|---|---|
| Betanis | ChEMBL |
| YM-178 | ChEMBL |
| Brand Names | Source |
|---|---|
| Betmiga | ChEMBL |
| Myrbetriq | ChEBI |
| Myrbetriq granules | ChEMBL |
| Registry Numbers | Sources |
|---|---|
| Reaxys:11023250 | Reaxys |
| CAS:223673-61-8 | ChemIDplus |
| CAS:223673-61-8 | KEGG DRUG |
| Citations |
|---|